These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32209187)

  • 1. [Erratum: Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2019 version)].
    Editorial Office of Chinese Journal of Lung Cancer
    Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):210. PubMed ID: 32209187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erratum: Current Status and Progress in Molecular Imaging of Non-small Cell Lung Cancer for Molecular Targeted EGFR-TKI Treatment Sensitivity and Treatment Tolerance Prediction].
    Editorial Office of Chinese Journal of Lung Cancer
    Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):49. PubMed ID: 31948541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erratum: Emerging Actions of Pterostilbene on Cancer Research].
    Editorial Office of Chinese Journal of Lung Cancer
    Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):195. PubMed ID: 32209186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction of "Effect of bufalin on proliferation and apoptosis of human non-small cell lung cancer A549 Cell. Zhongguo Fei Ai Za Zhi, 2010, 13(9): 841-845".
    Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1045. PubMed ID: 21081045
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction of " Lung cancer: microRNA and target database. Zhongguo Fei Ai Za Zhi, 2012, 15(7): 429-434".
    Kiran C; Deepika P
    Zhongguo Fei Ai Za Zhi; 2012 Aug; 15(8):470. PubMed ID: 22901994
    [No Abstract]   [Full Text] [Related]  

  • 6. Consensus on the use of immune-related response criteria to evaluate the efficacy of immunotherapy in non-small cell lung cancer.
    Provencio M; Carcereny E; Artal Á
    Clin Transl Oncol; 2019 Nov; 21(11):1464-1471. PubMed ID: 30903517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint inhibitors in advanced non-small cell lung cancer.
    Assi HI; Kamphorst AO; Moukalled NM; Ramalingam SS
    Cancer; 2018 Jan; 124(2):248-261. PubMed ID: 29211297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors.
    Kim HK; Heo MH; Lee HS; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):591-598. PubMed ID: 28733892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Brian et al. (2019).
    Adapt Phys Activ Q; 2019 Apr; 36(2):306. PubMed ID: 30630348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
    Li JS; Li SY; Yu XQ; Xie Y; Wang MH; Li ZG; Zhang NZ; Shao SJ; Zhang YJ; Zhu L; Guo LX; Bai YP; Wang YF
    J Ethnopharmacol; 2012 Jun; 141(2):584-91. PubMed ID: 21911051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
    Brahmer JR; Govindan R; Anders RA; Antonia SJ; Sagorsky S; Davies MJ; Dubinett SM; Ferris A; Gandhi L; Garon EB; Hellmann MD; Hirsch FR; Malik S; Neal JW; Papadimitrakopoulou VA; Rimm DL; Schwartz LH; Sepesi B; Yeap BY; Rizvi NA; Herbst RS
    J Immunother Cancer; 2018 Jul; 6(1):75. PubMed ID: 30012210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discussion on issues related to clinical experts consensus of Chinese patent medicine].
    Fang SN; Sun SL; Guo YB; Liao X; Liu JP; Chen W
    Zhongguo Zhong Yao Za Zhi; 2018 Dec; 43(24):4792-4795. PubMed ID: 30717521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Author Correction: Microglial immune checkpoint mechanisms.
    Deczkowska A; Amit I; Schwartz M
    Nat Neurosci; 2018 Aug; 21(8):1137. PubMed ID: 29942040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Author Correction: TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory pain.
    Wang Y; Gao Y; Tian Q; Deng Q; Wang Y; Zhou T; Liu Q; Mei K; Wang Y; Liu H; Ma R; Ding Y; Rong W; Cheng J; Yao J; Xu TL; Zhu MX; Li Y
    Nat Commun; 2018 Jun; 9(1):2593. PubMed ID: 29955059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERRATUM TO: Best Practices in Clinical Education: A Site Visit Decision-Making Model in Physical Therapist Education, Hochman L, et al., J Allied Health, Summer 2024.
    JAH Staff
    J Allied Health; 2024; 53(3):249. PubMed ID: 39293021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitors in lung cancer: current status and future directions.
    Fan Y; Mao W
    Chin Clin Oncol; 2017 Apr; 6(2):17. PubMed ID: 28482670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for immune checkpoint inhibitors in advanced nonsmall cell lung cancer.
    Pirker R
    Curr Opin Oncol; 2019 Jan; 31(1):24-28. PubMed ID: 30418192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum.
    Alcohol Clin Exp Res; 2017 Jul; 41(7):1385. PubMed ID: 28670840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum to: Extracranial contamination in the INVOS 5100C versus the FORE-SIGHT ELITE cerebral oximeter: a prospective observational crossover study in volunteers.
    Greenberg S; Murphy G; Shear T; Patel A; Simpson A; Szokol J; Avram MJ; Vender J
    Can J Anaesth; 2016 Apr; 63(4):512. PubMed ID: 26888637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.